• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-
-

2010 Warning Letters

Recently Posted | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

Warning Letters issued in 2010

 

* Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

* N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

Read more about warning and close-out letters

Posted on June 25, 2010

Letter Issue Date Company Name Issuing Office Subject Close Out Date
June 09, 2010 Busman Dairy Seattle District Office Illegal Drug Residue Not Issued *
June 08, 2010 Homeopathy For Health Center for Drug Evaluation and Research Unapproved/Uncleared/Unauthorized Products Related to the H1N1 Flu Virus Not Issued *
June 08, 2010 Piezosurgery Inc. Cincinnati District Office CGMP for Medical Devices/QS/Adulterated March 29, 2011
June 07, 2010 Mamma Lina's, Inc. Los Angeles District Office Seafood HACCP/Adulterated October 06, 2011
June 07, 2010 Arizant Inc Center for Devices and Radiological Health CGMP/QSR/Medical Device Reporting/Misbranded Not Issued *
June 07, 2010 Dick-mar Farms Philadelphia District Office Illegal Drug Residue Not Issued *
June 04, 2010 Atlas Operations, Inc. Florida District Office CGMP for Drugs/Manufacture, Processing, Packing, Holding/Adulterated Not Issued *
June 04, 2010 Troyer Farms Detroit District Office Animal Sale for Slaughter as Food/Adulterated April 01, 2011
June 03, 2010 Twin Oaks Community Foods, Inc Baltimore District Office Food Labeling/Misbranded July 19, 2011
June 03, 2010 Baxter Healthcare Corporation Chicago District Office Medical Device Reporting (MDR) Regulation/Adulterated Not Issued *


 

Contact FDA

301-796-8490
FDA's Office of Critical Path Programs
-
-
-